Published in Schizophr Bull on December 08, 2011
Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet (2013) 1.57
Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol (2015) 1.14
The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res (2012) 0.76
Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis. JAMA Psychiatry (2017) 0.75
Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain. Transl Psychiatry (2017) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab (1990) 3.78
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A (2000) 3.34
Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab (2000) 2.95
Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85
Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry (1999) 2.27
Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry (2010) 2.19
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des (2009) 1.51
Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia. Schizophr Bull (2000) 1.24
Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers. Neuropsychopharmacology (2009) 1.15
Presynaptic regulation of dopamine transmission in schizophrenia. Schizophr Bull (2009) 1.10
The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacol (2001) 1.08
Effects of age on dopamine transporters in healthy humans. J Nucl Med (1999) 1.04
Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J Nucl Med (2004) 1.00
Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res (2001) 0.96
Dopamine transporter binding in smokers and nonsmokers. Clin Nucl Med (2007) 0.92
Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait. Psychopharmacology (Berl) (2006) 0.92
Gender differences in age at onset of schizophrenia. Br J Psychiatry (1994) 0.89
Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys. PLoS One (2010) 0.87
MR-PET image coregistration for quantitation of striatal dopamine D2 receptors. J Comput Assist Tomogr (1996) 0.87
Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. Eur Arch Psychiatry Clin Neurosci (2005) 0.87
Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1. Schizophr Res (2003) 0.86
Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. Am J Psychiatry (2004) 0.85
Correlation between different memory systems and striatal dopamine D2/D3 receptor density: a single photon emission computed tomography study. Psychol Med (2005) 0.84
Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Biol Psychiatry (2000) 0.84
Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naïve schizophrenic patients. Schizophr Res (2007) 0.82
Sensory stimulation accelerates dopamine release in the basal ganglia. Brain Res (2004) 0.82
123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia. Psychopharmacology (Berl) (2004) 0.82
Dopamine transporter binding in rat striatum and nucleus accumbens is unaltered following chronic changes in dopamine levels. Neurosci Lett (1996) 0.80
The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1. J Psychopharmacol (2005) 0.79
In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates. Eur J Nucl Med (1999) 0.78
Fractal analysis of striatal dopamine re-uptake sites. Eur J Nucl Med (1997) 0.78
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet (2011) 5.56
Prevalence of mental incapacity in medical inpatients and associated risk factors: cross-sectional study. Lancet (2004) 5.33
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78
Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet (2009) 4.61
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet (2010) 4.42
Mental capacity to make decisions on treatment in people admitted to psychiatric hospitals: cross sectional study. BMJ (2008) 3.99
What are the consequences of deployment to Iraq and Afghanistan on the mental health of the UK armed forces? A cohort study. Lancet (2010) 3.63
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34
Predictors of amygdala activation during the processing of emotional stimuli: a meta-analysis of 385 PET and fMRI studies. Brain Res Rev (2007) 3.26
Prevalence and predictors of mental incapacity in psychiatric in-patients. Br J Psychiatry (2005) 2.99
A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry (2004) 2.65
A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry (2007) 2.48
Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry (2012) 2.39
Out-patient psychological therapies for adults with anorexia nervosa: randomised controlled trial. Br J Psychiatry (2012) 2.39
Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex (2002) 2.31
Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ (2013) 2.28
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Should the diagnostic boundaries of schizophrenia be expanded? Cogn Neuropsychiatry (2011) 2.07
Reliability of mental capacity assessments in psychiatric in-patients. Br J Psychiatry (2005) 2.07
Cognitive remediation therapy in schizophrenia: randomised controlled trial. Br J Psychiatry (2007) 2.06
Self-reflection and the brain: a theoretical review and meta-analysis of neuroimaging studies with implications for schizophrenia. Neurosci Biobehav Rev (2009) 2.05
Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res (2010) 1.98
A systematic review and quantitative appraisal of fMRI studies of verbal fluency: role of the left inferior frontal gyrus. Hum Brain Mapp (2006) 1.96
Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry (2004) 1.87
Is impaired set-shifting an endophenotype of anorexia nervosa? Am J Psychiatry (2005) 1.86
Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry (2004) 1.70
Distribution of symptom dimensions across Kraepelinian divisions. Br J Psychiatry (2006) 1.67
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry (2012) 1.64
Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed (2002) 1.63
Decision-making capacity for treatment in psychiatric and medical in-patients: cross-sectional, comparative study. Br J Psychiatry (2013) 1.62
Observations on haematological and cardiovascular effects of erythropoietin treatment in multiple system atrophy with sympathetic failure. Clin Auton Res (2002) 1.61
Neural systems underlying British Sign Language and audio-visual English processing in native users. Brain (2002) 1.60
Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology (2013) 1.56
Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.56
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Processing speed deficits in schizophrenia: reexamining the evidence. Am J Psychiatry (2010) 1.52
The risk factors of Internet addiction--a survey of university freshmen. Psychiatry Res (2009) 1.52
The mental health of UK Gulf war veterans: phase 2 of a two phase cohort study. BMJ (2002) 1.50
Working alliance and its relationship to outcomes in a randomized controlled trial (RCT) of antipsychotic medication. BMC Psychiatry (2013) 1.50
Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets. Eur Neuropsychopharmacol (2005) 1.49
Substantial shared genetic influences on schizophrenia and event-related potentials. Am J Psychiatry (2007) 1.48
Chronic fatigue syndrome. BMJ (2010) 1.46
Belief models in first episode schizophrenia in South India. Soc Psychiatry Psychiatr Epidemiol (2007) 1.46
The development of emotion-processing in children: effects of age, emotion, and intensity. J Child Psychol Psychiatry (2006) 1.45
Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry (2003) 1.38
Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness. Br J Psychiatry (2005) 1.38
Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol (2008) 1.38
Association between BDNF val66 met genotype and episodic memory. Am J Med Genet B Neuropsychiatr Genet (2005) 1.36
Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry (2006) 1.35
Fronto-limbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Psychiatry Res (2007) 1.34
The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry (2002) 1.34
Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp (2009) 1.32
Neural response to specific components of fearful faces in healthy and schizophrenic adults. Neuroimage (2009) 1.30
Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr Res (2007) 1.30
Neural correlates of executive function and working memory in the 'at-risk mental state'. Br J Psychiatry (2009) 1.29
Alterations in white matter evident before the onset of psychosis. Schizophr Bull (2012) 1.29
The neural correlates of intentional and incidental self processing. Neuropsychologia (2002) 1.28
A study on the sleep quality of incoming university students. Psychiatry Res (2012) 1.27
Insight in psychosis and neuropsychological function: meta-analysis. Br J Psychiatry (2006) 1.26
What causes the onset of psychosis? Schizophr Res (2005) 1.24
Dissociating linguistic and nonlinguistic gestural communication in the brain. Neuroimage (2004) 1.24
Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study. Br J Psychiatry (2010) 1.24
Depersonalisation disorder: clinical features of 204 cases. Br J Psychiatry (2003) 1.24
White matter microstructural impairments and genetic liability to familial bipolar I disorder. Br J Psychiatry (2009) 1.23
Gulf war illness--better, worse, or just the same? A cohort study. BMJ (2003) 1.23
Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study. Neuroimage (2005) 1.23
Heritability and reliability of P300, P50 and duration mismatch negativity. Behav Genet (2006) 1.22
Randomised controlled trial of parent groups for child antisocial behaviour targeting multiple risk factors: the SPOKES project. J Child Psychol Psychiatry (2009) 1.19
Mental capacity and psychiatric in-patients: implications for the new mental health law in England and Wales. Br J Psychiatry (2009) 1.18
A computational morphometric MRI study of schizophrenia: effects of hallucinations. Cereb Cortex (2002) 1.18
Insight in schizophrenia: involvement of self-reflection networks? Schizophr Bull (2012) 1.17
White matter integrity as a predictor of response to treatment in first episode psychosis. Brain (2013) 1.16
A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia. Biol Psychiatry (2006) 1.16
Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc Natl Acad Sci U S A (2009) 1.15
Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disord (2005) 1.15
Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet (2013) 1.15
The early auditory gamma-band response is heritable and a putative endophenotype of schizophrenia. Schizophr Bull (2009) 1.13
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry (2009) 1.13
Parkinson's disease motor subtypes and mood. Mov Disord (2011) 1.12
Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease? Mov Disord (2011) 1.12
P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biol Psychiatry (2006) 1.12
Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry (2012) 1.11
Mild traumatic brain injury in UK military personnel returning from Afghanistan and Iraq: cohort and cross-sectional analyses. J Head Trauma Rehabil (2012) 1.10
Unpacking the depersonalization syndrome: an exploratory factor analysis on the Cambridge Depersonalization Scale. Psychol Med (2005) 1.10
Neural correlates of British sign language comprehension: spatial processing demands of topographic language. J Cogn Neurosci (2002) 1.09
Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry (2013) 1.08